The Patent Finder

Thetis Pharmaceuticals LLC

Also on record
Records under this name other than the patents Thetis Pharmaceuticals LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Back to Thetis Pharmaceuticals LLC

PatentTitleStatus Expires Confidence
US 11,191,840Compositions and methods relating to salts of specialized pro-resolving mediators
Lapsed on the fee record
Ended Dec 7, 2025 · From the USPTO record
Lapsed on the fee recordEnded Dec 7, 2025From the USPTO record
US 11,135,298Compositions and methods relating to salts of specialized pro-resolving mediators
Lapsed on the fee record
Ended Oct 5, 2025 · From the USPTO record
Lapsed on the fee recordEnded Oct 5, 2025From the USPTO record
US 9,242,008Mineral amino-acid complexes of fatty acids
Lapsed on the fee record
Ended Jan 26, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jan 26, 2024From the USPTO record
US 10,399,552Method and device for operating a hydraulic brake system, brake system
Lapsed on the fee record
Ended Sep 3, 2023 · From the USPTO record
Lapsed on the fee recordEnded Sep 3, 2023From the USPTO record
US 8,901,107Lipid-lowering antidiabetic agent
Lapsed on the fee record
Ended Dec 2, 2022 · From the USPTO record
Lapsed on the fee recordEnded Dec 2, 2022From the USPTO record
US 8,765,811Tri-salt form of metformin
Lapsed on the fee record
Ended Jul 1, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jul 1, 2022From the USPTO record
US 9,999,626Mineral amino-acid complexes of active agents
Lapsed on the fee record
Ended Jun 19, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jun 19, 2022From the USPTO record
US 9,505,709Compositions and methods relating to ionic salts of peptides
Lapsed on the fee record
Ended Nov 29, 2020 · From the USPTO record
Lapsed on the fee recordEnded Nov 29, 2020From the USPTO record
US 9,382,187Tri-salt form of metformin
Lapsed on the fee record
Ended Jul 5, 2020 · From the USPTO record
Lapsed on the fee recordEnded Jul 5, 2020From the USPTO record
US 9,216,951Lipid-lowering antidiabetic agent
Lapsed on the fee record
Ended Dec 22, 2019 · From the USPTO record
Lapsed on the fee recordEnded Dec 22, 2019From the USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited